All Articles

Litigation attorney R. Brandon McCullough contributed significantly to the content and publication of Unfair Claims Settlement Practices Compendium published by DRI which is now available for purchase. […]

In addition to discussing the risks associated with opioid therapies, Senate Bill 1152 would require physicians to enter into “treatment agreements” with patients. […]

Robert J. Burnett has been re-elected to the Pennsylvania chapter of the National Association of Royalty Owners Board of Directors for a third consecutive term. A member of its legislative committee, he has been active in NARO’s ongoing effort to amend and clarify Pennsylvania’s Guaranteed Minimum Royalty Act. […]

Each year, no more than five percent of lawyers in the state are selected as “Super Lawyers,” and no more than 2.5 percent are selected to the Rising Stars list. […]

Physicians registered to participate in the medical marijuana program should pay close attention to these changes to ensure compliance with state medical marijuana program regulations, […]

Landmark decision by PA Superior Court – “rule of capture” does not apply to frac fissures that extend under unleased parcels. Driller cannot remove hydrocarbons from the shale formations beneath your property unless you have signed an oil and gas lease […]

The IoT raises a variety of insurance coverage issues. Commercial general liability policies raise the issue of whether a defective product claim arising from the IoT will qualify as an “occurrence.” Exclusions may limit coverage when a product is a component in a larger product and the larger product is damaged […]

Because a typical medical practice may consist of predominantly male owners and predominantly female staff, a practice may be especially vulnerable to sexual misconduct claims, […]

In a remarkable 34-0 vote on February 28, 2018, the West Virginia Senate passed SB 360, which essentially reverses and nullifies the West Virginia Supreme Court’s controversial decision in Leggett v. EQT Production. […]

The rescission of the Cole and Ogden memoranda guidance may cause concern for participants in Pennsylvania’s medical marijuana industry regarding future enforcement initiatives. […]